Bryn Mawr, PA, United States of America

Luigi Grasso

USPTO Granted Patents = 71 

 

 

Average Co-Inventor Count = 4.1

ph-index = 8

Forward Citations = 278(Granted Patents)


Inventors with similar research interests:


Location History:

  • Philadelphia, PA (US) (2003 - 2012)
  • Bala Cynwyd, PA (US) (2007 - 2019)
  • Bryn Mawr, PA (US) (2010 - 2021)

Company Filing History:


Years Active: 2003-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Antibody Dynamics
Monoclonal Antibodies
Tumor Antigens
Neutralizing Antibodies
Folate Receptor Alpha
Endosialin Binding
GM-CSF Peptides
Hybridoma Technology
Hypermutable Microbes
Genetically Altered Antibodies
Chemical Inhibitors
Antimicrobial Agents
71 patents (USPTO):Explore Patents

Title: The Innovator Profile: Luigi Grasso

Introduction

Luigi Grasso, a prolific inventor based in Bryn Mawr, PA, is recognized for his significant contributions to the field of biotechnology with an impressive portfolio of 70 patents. His groundbreaking work has led to the development of novel immunoglobulins and monoclonal antibodies that hold promise in the treatment of various cancers.

Latest Patents

Among his latest patents is the innovative method for generating conjugated immunoglobulins by decapping a cysteine at amino acid position 80 ('Cys80') in a light chain variable region of an immunoglobulin and conjugating a thiol-reactive compound to the Cys80. Additionally, Grasso's invention of monoclonal antibodies that specifically block the biological activity of a tumor antigen, particularly the alpha-folate receptor, showcases his ingenuity in targeting cancer cells with precision.

Career Highlights

Having worked at esteemed institutions such as Morphotek, Inc. and The Johns Hopkins University, Luigi Grasso has honed his skills and expertise in the biotechnology sector. His relentless pursuit of innovation and dedication to advancing cancer treatment have earned him recognition among his peers and in the industry.

Collaborations

Throughout his career, Luigi Grasso has collaborated with notable professionals in the field, including coworkers Nicholas C Nicolaides and Philip M Sass. Together, they have brought forth cutting-edge research and developments that have the potential to transform the landscape of cancer therapeutics.

Conclusion

In conclusion, Luigi Grasso stands out as a visionary inventor whose relentless pursuit of innovation has led to groundbreaking advancements in biotechnology, particularly in the development of immunoglobulins and monoclonal antibodies for cancer treatment. His contributions continue to inspire progress in the field, offering hope for improved therapies and outcomes for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…